In breast cancer, which is the second most frequent cause of central nervous system (CNS) metastases, brain lesions primarily occur in triple‐negative (estrogen receptor‐, progesterone receptor‐, and Her2‐negative) and Her2/neu‐overexpressing subtypes. Here, ERBB2 is linked to breast cancer.